Genome-Wide Association Studies (GWAS) Loci

Subject Name : Medical Sciences

Introduction

Genetic mapping's success and the development of personalised treatment are governed by the genetic architecture that underlies human diseases. Contradictory notions about the characteristics of genetic architecture (such as the role of uncommon vs common variants) have been championed even though various research has questioned the genetic basis of prevalent diseases. To facilitate the systematic evaluation of such hypotheses, we created an integrated simulation framework that was calibrated to empirical data (1).

Eczema, a common inflammatory skin condition impacting 15–30% of children and 5%–10% of adults, is also known as atopic dermatitis. Anomalies of the epidermal barrier and cutaneous inflammation brought on by T cells are involved in its aetiology. The complicated disease atopic dermatitis (AD), which affects people with certain genetic predispositions, is believed to be brought on by environmental triggers. The null (loss-of-function) mutations of the gene encoding filaggrin (FLG), located on chromosome 1q21.3, are the strongest known genetic risk factor for Alzheimer's disease (AD), with twin studies estimating the heritability of the disease to be over 75%. In the developing pathogenesis paradigm for AD, which combines skin barrier function and adaptive and innate immunity, the identification of the filaggrin gene was significant. More than 30 genetic loci have been connected to AD across numerous populations, helped along by the recent advancement of large-scale high-throughput genomics (6).

With estimates of heritability of as high as 90 in Europeans, genetics have a significant role in atopic dermatitis (2). Despite heritability estimates indicating that genetic factors account for a major portion of the risk of developing eczema, the genetics underlying these disorders has not been adequately explained by earlier research (3). For instance, null mutations of the FLG gene (which codes for filaggrin), which cause a weakness in the epidermal barrier, are the main risk factors currently understood. Genome-wide association studies (GWAS) have found 20 new loci, largely associated with immunological dysregulation (ten in European, eight in Japanese, and two in Chinese populations). According to genetic modelling, well-powered GWAS could find additional loci (2).

Additionally recognised as crucial for AD are genetic factors. Twin studies put the heredity of AD at 75%. Genome-wide association studies (GWASs) have previously been carried out, revealing a significant number of variations that were mapped to 37 distinct loci across the genome. While some of these loci are shared by different populations, others are population-specific. As a crucial gene for epidermal barrier dysfunction, FLG, which codes for filaggrin, has been linked to AD in both European (EUR) and non-EUR GWASs. In multi-population GWASs, IL13 in the TH2-related pathway, IL1R1-IL18RAP, and HLA were also proposed (4).

Numerous techniques can be used to examine the structural makeup of complex diseases, including family-based connection scans, genome-wide association studies (GWAS), "polygene" analyses that combine information from many common modifications, and (more recently) genome sequencing in phenotype individuals. To yet, only about 5-20 % of the heritability for the majority of prevalent diseases has been explained (mainly by loci found in GWAS), even though each particular study design offers a restricted window into the whole architecture underlying a given characteristic (5).

One of the studies accomplished a replication in 32,059 cases and 228,628 controls from 18 studies after performing a meta-analysis of >15 million genetic variants in 21,399 cases and 95,464 controls from populations with European, African, Japanese, and Latino ancestry. The overall number of identified atopic dermatitis hazard loci has increased to 31 as a result of our discovery of ten additional risk loci. Notably, the discovered loci contain candidate genes involved in the control of innate host defences and T cell activity, highlighting the significant role that (auto)immune systems play in the aetiology of atopic dermatitis (2). Owing to the description of GWAS relevant to atopic dermatitis, the genome-wide analysis of one of the loci detected, rs10791824_chr11_GWAS, was analysed in the present report.

Gene Regulation of rs10791824_chr11_GWAS

The knowledge of how genetic variation causes disease has considerably advanced with the combination of GWAS associations and cell type-specific functional data. On one side, cell types or tissues can now be prioritised according to how relevant they are to a given disease. This is made possible by SNP enrichment techniques. These procedures function by looking for the accumulation of variations in the regulatory components unique to a particular cell type. They may be limited to important variants over the entire genome or may estimate enrichments according to the contributions made by all SNPs. Colocalization analysis, on the other hand, uses LD data and association patterns to combine eQTL with GWAS associations to discover the target genes for GWAS loci. TWAS also permits the use of transcriptome imputation to directly link genes and phenotypes (8).

It is expected that research employing self-reporting would have a modest level of phenotypic misclassification, whereas studies with phenotype characterization based on a dermatologist exam tended to report greater effect sizes. When evaluating the odds ratios from our investigation, it is important to keep in mind that the inclusion of studies utilising self-reporting is likely to bias estimations of effect magnitude towards the null. Given that the primary goal of GWAS is the discovery of new loci, the increase in sample size attained by incorporating these studies is so substantial that any potential negative impact on statistical power is more compared to outweighed, and the anticipated pattern of bias makes it unlikely that there will be a problem with spurious findings (7).

Numerous loci connected to atopic dermatitis (AD) have been found by GWASs. Some have validated previously held beliefs, such as the importance of the skin barrier and type 2 inflammation in the aetiology of AD, while others have revealed fresher understandings, such as proof of autoimmunity and previously unknown genes driving epidermal differentiation. The bulk of risk loci are found in intergenic areas, the functional mechanism(s) for which are still unknown. In-depth molecular investigations at these loci must be conducted in AD-relevant cells and tissues. To completely understand individual risk, much more research is required because genomic discoveries to date only explain about 30% of AD heredity (7).

The analysis of the rs10791824_chr11 loci revealed several positions of indel (insertion and deletion). 21 genome-wide significant (P 5 108) loci were found by a fixed-effects meta-analysis of the power source 22 European studies, and an additional six loci with a log10 (Bayes factor) > 6.1 were found by a multi-ancestry meta-analysis, of which four (10q21.2, 6p21.33, 11p13, and 2p13.3) also demonstrated nominal association in a European analysis. These 27 loci comprised all 11 previously identified European loci linked to atopic dermatitis as well as five Japanese loci. The European research found strong associations between three loci found in Japanese (6p21.33, 10q21.2, and 2q12.1) as well (2).

Figure 1: The loci (highlighted in yellow) along with the gene covered in the analysis (Adapted from ref: 2)

Figure 2: The analysis of loci rs10791824_chr11 using the UCSC Genome Browser

From the analysis of loci rs10791824_chr11 using the UCSC Genome Browser, the single nucleotide polymorphism is evident at certain positions. These nucleotide variations are A/G/T.

Figure 3: Description of variation in alleles at the given loci (Adapted from dbSNP)

Figure 4: Few positions on the loci rs10791824_chr11 where INDEL is evident

Linkage Disequilibrium Analysis of loci rs10791824_chr11

There have been five genome-wide studies on AD to date, and one genome-wide screening with a focus on AD. These investigations, except for a Japanese study, were carried out on patients from Europe. This linkage study’s findings suggest possible locations on the chromosomes 3q14, 13q14, 15q14–15, 17q21, 4q22, 3p24, 3q21, 1q21, 17q25, 20p, 5q13, 11p14, 3p, 4p, 18q, 15q21, and 1q24, but they are very different from one another and none of the loci could be successfully replicated (9). From this analysis, it is evident that chromosome 11 is involved in the genetic occurrences of Eczema. Figure 5 suggested that the variation is created by C, G and T where A nucleotide changes to either C, G and T.

Figure 5: Linkage Disequilibrium analysis of the loci rs10791824_chr11 (Generated from LDLink set of tools)

In our GWA studies, we have included cases of all people who reported either having eczema, regardless of whether they also reported having the other disease phenotype. To look into potential phenotypic-specific SNPs, we used polytomous (multinomial) logistic regression to determine whether the effect of a locus (lead SNP) was substantially (FDR 0.05) higher for one disease phenotype as opposed to another (FDR 0.05). As a result, it might be said that these effects are phenotype or illness specific.

Conclusion

The most widespread allergy condition in the world is called atopic dermatitis (AD). While genetic factors are crucial to its pathophysiology, a sizable percentage of its genetic history is yet unknown. One of the most prevalent allergy illnesses, atopic dermatitis (AD) mostly affects the skin. AD typically appears in infancy or early childhood, and individuals who present with it at a young age frequently experience severe symptoms. Asthma, allergic rhinoconjunctivitis, and food allergies are atopic comorbidities that are linked to AD. Other non-atopic conditions such as inflammatory diseases and psychosocial disorders are also linked to AD. The genetic predisposition for atopic comorbidities is shared, according to genetic association studies. According to twin studies, there is about 75% heritability for AD, and genetic pleiotropy accounts for around 85% of the connection between asthma and AD (11).

In the earlier reported studies, a total of 62 genes and 5 intergenic areas were identified as being connected to AD; 32 of these connections were made with the illness for the first time during this time. Over 90% of the other genes were reported, with filaggrin being the most prevalent. In the present report, rs10791824_chr11 loci were described, among which the nearest reported gene was ovol1. Although there was little indication of consistency in the direction of effect, SNPs that were strongly linked with other autoimmune disorders were also more probable to be nominally linked to atopic dermatitis than would be expected by chance.

By using GWASs, several loci linked to atopic dermatitis (AD) were discovered. While some have confirmed long-held notions, such as the significance of the barrier formed by the skin and type 2 inflammation as part of the aetiology of AD, others have offered newer insights, such as evidence of autoimmunity and newly unidentified genes regulating epidermal development. Intergenic regions contain the majority of risk loci, whose functional mechanism(s) are currently unclear (1).

As a result, a locus associated with AD is reported in the document. However, there is evidence of other loci as a secondary signal. with evidence of secondary signals at four of these loci. Moreover, six of these loci also reach genome-wide significance in random-effects analysis across studies of all ancestry groups. Overall, in the subset of European studies with clinically diagnosed cases, the previously known and newly discovered variations account for 12.3% and 2.6%, respectively, of the variance in liability. There is strong evidence linking the innate immune system to the development of the illness and certain genes linked to AD have been linked to innate immune system pathways. In support of this, the majority of the review's genes related to innate immune pathways (ADAM33, MIF, MMP9, ORM2, RETN, and TLR2) are connected to neutrophil degranulation, which adds to the tissue inflammation in AD (11).

References

Agarwala V, Flannick J, Sunyaev S, GoT2D Consortium, Altshuler D. Evaluating empirical bounds on complex disease genetic architecture. Nature genetics. 2013 Dec;45(12):1418-27.
Ried JS, Li J, Zuo XB, Zheng XD, Yin XY, Sun LD, McAleer MA, O'Regan GM, Fahy CM, Campbell LE. Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nature genetics. 2015 Dec;47(12):1449-56.
Johansson Å, Rask-Andersen M, Karlsson T, Ek WE. Genome-wide association analysis of 350 000 Caucasians from the UK Biobank identifies novel loci for asthma, hay fever and eczema. Human molecular genetics. 2019 Dec 1;28(23):4022-41.
Tanaka N, Koido M, Suzuki A, Otomo N, Suetsugu H, Kochi Y, Tomizuka K, Momozawa Y, Kamatani Y, Ikegawa S, Yamamoto K. Eight novel susceptibility loci and putative causal variants in atopic dermatitis. Journal of Allergy and Clinical Immunology. 2021 Nov 1;148(5):1293-306.
Thornton KR, Foran AJ, Long AD. Properties and modelling of GWAS when complex disease risk is due to non-complementing, deleterious mutations in genes of large effect. PLoS genetics. 2013 Feb 21;9(2):e1003258.
Tanaka N, Koido M, Suzuki A, Otomo N, Suetsugu H, Kochi Y, Tomizuka K, Momozawa Y, Kamatani Y, Ikegawa S, Yamamoto K. Eight novel susceptibility loci and putative causal variants in atopic dermatitis. Journal of Allergy and Clinical Immunology. 2021 Nov 1;148(5):1293-306.
Brown SJ. What have we learned from GWAS for atopic dermatitis?. Journal of Investigative Dermatology. 2021 Jan 1;141(1):19-22.
Loset M, Brown SJ, Saunes M, Hveem K. Genetics of atopic dermatitis: from DNA sequence to clinical relevance. Dermatology. 2019;235(5):355-64.
Choi EH. Genetics of atopic dermatitis. InPractical Insights into Atopic Dermatitis 2021 May 1 (pp. 65-74). Singapore: Springer Singapore.
Kumar D, Puan KJ, Andiappan AK, Lee B, Westerlaken GH, Haase D, Melchiotti R, Li Z, Yusof N, Lum J, Koh G. A functional SNP associated with atopic dermatitis controls cell type-specific methylation of the VSTM1 gene locus. Genome Medicine. 2017 Dec;9(1):1-6.
Huls A, Klümper C, MacIntyre EA, Brauer M, Melén E, Bauer M, Berdel D, Bergström A, Brunekreef B, Chan‐Yeung M, Fuertes E. Atopic dermatitis: Interaction between genetic variants of GSTP 1, TNF, TLR 2, and TLR 4 and air pollution in early life. Pediatric Allergy and Immunology. 2018 Sep;29(6):596-605.